By Josh White
Date: Tuesday 30 Apr 2024
(Sharecast News) - Faron Pharmaceuticals announced on Tuesday that it has extended its agreement with lender IPF to ensure continued financial support as it progressed towards securing longer-term funding.
By Iain Gilbert
Date: Monday 15 Apr 2024
(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals revealed on Monday that chief financial officer James O'Brien would be leaving the group to "pursue another career opportunity".
By Iain Gilbert
Date: Monday 08 Apr 2024
(Sharecast News) - Biopharmaceutical company Faron Pharmaceuticals named Dr Juho Jalkanen as its next chief executive officer on Monday.
Currency | UK Pounds |
Share Price | 185.00p |
Change Today | 7.50p |
% Change | 4.23 % |
52 Week High | 350.00 |
52 Week Low | 117.50 |
Volume | 25,070 |
Shares Issued | 72.01m |
Market Cap | £133.21m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 1 |
Strong Sell | 1 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
16:12 | 589 @ 187.00p |
16:07 | 2,500 @ 187.00p |
15:46 | 2,667 @ 187.00p |
15:14 | 546 @ 183.00p |
15:10 | 15,000 @ 186.00p |
CEO | Juho Jalkanen |
Chair | Tuomo Pätsi |
You are here: research